Psychedelic Microdosing Effects on Mood, Cognition, Subjective Well-being and MRI

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Psychedelic Microdosing Effects on Mood, Cognition, Subjective Well-being and MRI trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Not Yet RecruitingEarly Phase 1

NCT07449351

Psilocybin Microdosing on Cognition, Mood and Quality of Life

This study is being conducted to evaluate how of 30 days of intermittently microdosed psilocybin affects mood, cognition, subjective well-being and structural/f…

United States20 participantsStarted 2026-04-01

Treatment: Psliocybin, Placebo